lynestrenol has been researched along with Carcinoma in Situ in 2 studies
Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andolśek, L | 1 |
| Kovaćic, J | 1 |
| Koźuh, M | 1 |
| Litt, B | 1 |
| Dallenbach-Hellweg, G | 1 |
2 other studies available for lynestrenol and Carcinoma in Situ
| Article | Year |
|---|---|
Influence of oral contraceptives on the incidence of premalignant and malignant lesions of the cervix.
Topics: Adolescent; Adult; Age Factors; Carcinoma; Carcinoma in Situ; Contraceptives, Oral; Contraceptives, | 1983 |
[Occurrence and histological structure of adenocarcinoma of the endocervix after long-term use of oral contraceptives (author's transl)].
Topics: Adenocarcinoma; Adult; Carcinoma in Situ; Cell Differentiation; Contraceptives, Oral; Contraceptives | 1982 |